Immuneering Corp Quarterly Operating Income (Loss) in USD from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Immuneering Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- Immuneering Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.3M, a 9.68% decline year-over-year.
- Immuneering Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$61.8M, a 10.2% decline year-over-year.
- Immuneering Corp annual Operating Income (Loss) for 2023 was -$58.4M, a 12.9% decline from 2022.
- Immuneering Corp annual Operating Income (Loss) for 2022 was -$51.7M, a 52.7% decline from 2021.
- Immuneering Corp annual Operating Income (Loss) for 2021 was -$33.9M, a 98.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)